Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>sALCL>R *** > Treatment > USA. S. Brentuximab Vedotin>

---

USA. S. Brentuximab Vedotin>'s subsections
(*) USA Approval Date: 2011. 08.19
>After Failure>1 Prior Multi Ag. CT
>for Inj.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2011. 10.25.
TradeMark
TradeMark Web-Site

USA. S. Brentuximab Vedotin>'s products
This section has no products